Luye Pharma Group Ltd. (2186.HK)
HKD 2.17
(-2.25%)
HKD 2.17
(-2.25%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 6.14 Billion | 5.98 Billion | 5.2 Billion | 5.53 Billion | 6.35 Billion | 5.17 Billion |
| Cost of Revenue | 1.93 Billion | 1.84 Billion | 1.8 Billion | 1.54 Billion | 1.47 Billion | 1.12 Billion |
| Gross Profit | 4.2 Billion | 4.14 Billion | 3.39 Billion | 3.99 Billion | 4.87 Billion | 4.04 Billion |
| Operating Expenses | 3.28 Billion | 3.18 Billion | 3.11 Billion | 2.77 Billion | 3.01 Billion | 2.53 Billion |
| Selling, General and Administrative Expenses | 2.7 Billion | 2.4 Billion | 2.27 Billion | 2.18 Billion | 2.56 Billion | 2.12 Billion |
| Research and Development Expenses | 586.15 Million | 857.33 Million | 683.15 Million | 789.86 Million | 579.45 Million | 491.16 Million |
| Other Expenses | - | -73.26 Million | 155.15 Million | -199.89 Million | -121.04 Million | 7.8 Million |
| Cost and Expenses | 5.22 Billion | 5.02 Billion | 4.91 Billion | 4.32 Billion | 4.49 Billion | 3.65 Billion |
| Operating Income | 887.43 Million | 1.21 Billion | 386.98 Million | 1.41 Billion | 1.98 Billion | 1.51 Billion |
| Interest Expense | 675.45 Million | 471.75 Million | 399.45 Million | 424 Million | 274.6 Million | 170.57 Million |
| Income Tax Expense | 161.02 Million | 86.46 Million | 70.22 Million | 238.9 Million | 279.82 Million | 167.47 Million |
| Earnings before Tax | 700.1 Million | 669.76 Million | -74.55 Million | 942.17 Million | 1.77 Billion | 1.47 Billion |
| Net Income | 532.6 Million | 604.8 Million | -144.78 Million | 706.58 Million | 1.46 Billion | 1.3 Billion |
| Earnings Per Share Basic | 0.14 | 0.17 | -0.04 | 0.22 | 0.46 | 0.41 |
| Earnings Per Share Diluted | 0.14 | 0.17 | -0.04 | 0.22 | 0.46 | 0.40 |
| Weighted Average Shares Outstanding | 3.72 Billion | 3.48 Billion | 3.44 Billion | 3.18 Billion | 3.2 Billion | 3.2 Billion |
| Weighted Average Shares Outstanding (Diluted) | 3.72 Billion | 3.48 Billion | 3.44 Billion | 3.19 Billion | 3.22 Billion | 3.22 Billion |
| Gross Margin | 0.68 | 0.69 | 0.65 | 0.72 | 0.77 | 0.78 |
| EBIT Margin | 0.34 | 0.32 | 0.19 | 0.35 | 0.38 | 0.38 |
| Profit Margin | 0.09 | 0.10 | -0.03 | 0.13 | 0.23 | 0.25 |
| EBITDA | 2.07 Billion | 1.81 Billion | 906.88 Million | 1.87 Billion | 2.38 Billion | 1.96 Billion |
| Earnings Before Tax Margin | 0.14 | 0.20 | 0.07 | 0.26 | 0.31 | 0.29 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 1.53 Billion | 1.53 Billion | 6.14 Billion | 1.61 Billion | 1.61 Billion | 1.45 Billion |
| Cost of Revenue | 498.01 Million | 498.01 Million | 1.93 Billion | 489.07 Million | 489.07 Million | 480.37 Million |
| Gross Profit | 1.03 Billion | 1.03 Billion | 4.2 Billion | 1.13 Billion | 1.13 Billion | 971.68 Million |
| Operating Expenses | 710.45 Million | 710.45 Million | 3.17 Billion | 789.27 Million | 789.87 Million | 729.41 Million |
| Selling, General and Administrative Expenses | 570 Million | 570 Million | - | 643.77 Million | 643.77 Million | 706.29 Million |
| Research and Development Expenses | 140.45 Million | 140.45 Million | - | 145.5 Million | 145.5 Million | 147.57 Million |
| Other Expenses | - | - | 284 Thousand | - | - | - |
| Cost and Expenses | 1.2 Billion | 1.2 Billion | 5.11 Billion | 1.27 Billion | 1.27 Billion | 1.2 Billion |
| Operating Income | 328.81 Million | 328.81 Million | 887.43 Million | 341.13 Million | 340.16 Million | 103.55 Million |
| Interest Expense | - | - | 675.45 Million | - | - | 347.01 Million |
| Income Tax Expense | 45.89 Million | 45.89 Million | 161.02 Million | 38.69 Million | 38.69 Million | 41.81 Million |
| Earnings before Tax | 264.98 Million | 264.98 Million | 700.1 Million | 235.55 Million | 235.55 Million | 114.49 Million |
| Net Income | 193.91 Million | 193.91 Million | 532.6 Million | 191.31 Million | 191.31 Million | 74.98 Million |
| Earnings Per Share Basic | 0.05 | 0.05 | - | 0.05 | 0.05 | 0.02 |
| Earnings Per Share Diluted | 0.05 | 0.05 | - | 0.05 | 0.05 | 0.02 |
| Weighted Average Shares Outstanding | 3.76 Billion | 3.76 Billion | 3.72 Billion | 3.76 Billion | 3.76 Billion | 3.69 Billion |
| Weighted Average Shares Outstanding (Diluted) | 3.76 Billion | 3.76 Billion | 3.72 Billion | 3.76 Billion | 3.76 Billion | 3.69 Billion |
| Gross Margin | 0.68 | 0.68 | 0.68 | 0.70 | 0.70 | 0.67 |
| EBIT Margin | 0.31 | 0.31 | - | 0.32 | 0.32 | 0.18 |
| Profit Margin | 0.13 | 0.13 | 0.09 | 0.12 | 0.12 | 0.05 |
| EBITDA | 469.73 Million | 469.73 Million | - | 514.31 Million | 514.31 Million | 262.14 Million |
| Earnings Before Tax Margin | 0.21 | 0.21 | 0.14 | 0.21 | 0.21 | 0.07 |
1801
0QW7
CCB
603317
DUFRY
0I4X